197 related articles for article (PubMed ID: 34129856)
1. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
[TBL] [Abstract][Full Text] [Related]
2. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
[TBL] [Abstract][Full Text] [Related]
3. Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist.
Pickford P; Lucey M; Rujan RM; McGlone ER; Bitsi S; Ashford FB; Corrêa IR; Hodson DJ; Tomas A; Deganutti G; Reynolds CA; Owen BM; Tan TM; Minnion J; Jones B; Bloom SR
Mol Metab; 2021 Sep; 51():101242. PubMed ID: 33933675
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling.
Lei S; Meng Q; Liu Y; Liu Q; Dai A; Cai X; Wang MW; Zhou Q; Zhou H; Yang D
Eur J Pharmacol; 2024 Apr; 968():176419. PubMed ID: 38360293
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists.
Fletcher MM; Halls ML; Zhao P; Clydesdale L; Christopoulos A; Sexton PM; Wootten D
Biochem Pharmacol; 2018 Oct; 156():406-419. PubMed ID: 30195733
[TBL] [Abstract][Full Text] [Related]
6. The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment and internalisation.
McNeill SM; Lu J; Marion C Carino C; Inoue A; Zhao P; Sexton PM; Wootten D
Biochem Pharmacol; 2024 Apr; 222():116119. PubMed ID: 38461904
[TBL] [Abstract][Full Text] [Related]
7. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
[TBL] [Abstract][Full Text] [Related]
8. Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists.
Lucey M; Pickford P; Bitsi S; Minnion J; Ungewiss J; Schoeneberg K; Rutter GA; Bloom SR; Tomas A; Jones B
Mol Metab; 2020 Jul; 37():100991. PubMed ID: 32278079
[TBL] [Abstract][Full Text] [Related]
9. Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells.
Fang Z; Chen S; Manchanda Y; Bitsi S; Pickford P; David A; Shchepinova MM; Corrêa IR; Hodson DJ; Broichhagen J; Tate EW; Reimann F; Salem V; Rutter GA; Tan T; Bloom SR; Tomas A; Jones B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182425
[TBL] [Abstract][Full Text] [Related]
10. Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists.
Hinds CE; Peace E; Chen S; Davies I; El Eid L; Tomas A; Tan T; Minnion J; Jones B; Bloom SR
Diabetes Obes Metab; 2024 Jan; 26(1):65-77. PubMed ID: 37795639
[TBL] [Abstract][Full Text] [Related]
11. Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism.
Xiao J; El Eid L; Buenaventura T; Boutry R; Bonnefond A; Jones B; Rutter GA; Froguel P; Tomas A
Diabetes Obes Metab; 2023 Aug; 25(8):2105-2119. PubMed ID: 37039251
[TBL] [Abstract][Full Text] [Related]
12. Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects.
Zhang H; Sturchler E; Zhu J; Nieto A; Cistrone PA; Xie J; He L; Yea K; Jones T; Turn R; Di Stefano PS; Griffin PR; Dawson PE; McDonald PH; Lerner RA
Nat Commun; 2015 Dec; 6():8918. PubMed ID: 26621478
[TBL] [Abstract][Full Text] [Related]
13. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
14. Divergent acute versus prolonged pharmacological GLP-1R responses in adult β cell-specific β-arrestin 2 knockout mice.
Bitsi S; El Eid L; Manchanda Y; Oqua AI; Mohamed N; Hansen B; Suba K; Rutter GA; Salem V; Jones B; Tomas A
Sci Adv; 2023 May; 9(18):eadf7737. PubMed ID: 37134170
[TBL] [Abstract][Full Text] [Related]
15. GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo.
Arcones AC; Vila-Bedmar R; Mirasierra M; Cruces-Sande M; Vallejo M; Jones B; Tomas A; Mayor F; Murga C
BMC Biol; 2021 Mar; 19(1):40. PubMed ID: 33658023
[TBL] [Abstract][Full Text] [Related]
16. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells.
Buenaventura T; Kanda N; Douzenis PC; Jones B; Bloom SR; Chabosseau P; Corrêa IR; Bosco D; Piemonti L; Marchetti P; Johnson PR; Shapiro AMJ; Rutter GA; Tomas A
Diabetes; 2018 Mar; 67(3):385-399. PubMed ID: 29284659
[TBL] [Abstract][Full Text] [Related]
17. The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines.
Douros JD; Mokrosinski J; Finan B
J Endocrinol; 2024 May; 261(2):. PubMed ID: 38451873
[TBL] [Abstract][Full Text] [Related]
18. Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects.
Zhong X; Chen Z; Chen Q; Zhao W; Chen Z
Molecules; 2019 Feb; 24(4):. PubMed ID: 30795583
[TBL] [Abstract][Full Text] [Related]
19. Targeting GLP-1 receptor trafficking to improve agonist efficacy.
Jones B; Buenaventura T; Kanda N; Chabosseau P; Owen BM; Scott R; Goldin R; Angkathunyakul N; Corrêa IR; Bosco D; Johnson PR; Piemonti L; Marchetti P; Shapiro AMJ; Cochran BJ; Hanyaloglu AC; Inoue A; Tan T; Rutter GA; Tomas A; Bloom SR
Nat Commun; 2018 Apr; 9(1):1602. PubMed ID: 29686402
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
